Raltegravir (RAL, Isentress, formerly MK-0518) is an antiretroviral drug produced by Merck & Co., used to treat HIV infection. It received approval by the U.S. Food and Drug Administration (FDA) on 12 October 2007, the first of a new class of HIV drugs, the integrase inhibitors, to receive such approval. In December 2011, it received FDA approval ...
Found on
http://en.wikipedia.org/wiki/Raltegravir
(from the article `Health and Disease`) ...Pfizer and received approval from the U.S. Food and Drug Administration in August. The drug would be used to treat people with advanced HIV/AIDS ...
Found on
http://www.britannica.com/eb/a-z/r/8
No exact match found.
